Status:
RECRUITING
Role of Red Blood Cells in Cardiovascular Disease
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Karolinska University Hospital
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
25-80 years
Brief Summary
The risk of myocardial infarction is dependent on cardiovascular risk factors including type 2 diabetes (T2D) but underlying mechanisms are poorly understood. We identified that red blood cells (RBCs)...
Detailed Description
The function of RBCs are investigated in functional bioassays and cell culture systems. The bioassays include isolated hearts subjected to ischemia-reperfusion and isolated arteries. the readouts are ...
Eligibility Criteria
Inclusion
- Type 2 diabetes
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2031
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT07151222
Start Date
January 1 2017
End Date
December 30 2031
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institutet
Stockholm, Swsden, Sweden, 17176